Erythropoiesis Stimulating Agents and Techniques: A Challenge for Doping Analysts

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|10|1236-1247

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.10, 2009-04, pp. : 1236-1247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erythropoiesis-Stimulating Agents in Oncology

By Glaspy John A.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 6, 2008-07 ,pp. : 565-575

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Management of Anaemia: A Critical and Systematic Review of the Cost Effectiveness of Erythropoiesis-Stimulating Agents

By Mei Sheng Duh  

PharmacoEconomics, Vol. 26, Iss. 2, 2008-01 ,pp. : 99-120

Adis International

Access to resources Recommend Favorite

Erythropoiesis-stimulating agents in patients with cancer: update on safety issues

By Pirker Robert  

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 515-522

Informa Healthcare

Access to resources Recommend Favorite

Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: data are safer than extrapolations

By Abraham Ivo   MacDonald Karen  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 885-887

Informa Healthcare

Access to resources Recommend Favorite

Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease

By Del Vecchio Lucia   Locatelli Francesco  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 923-931

Informa Healthcare

Access to resources Recommend Favorite